Allarity TherapeuticsALLR
13F holders, Q1 2025 (March 31)9holders +3
6new positions
3sold out
$0.94avg. 13F price*
At the end of Q1 2025, 9 institutions reported holding Allarity Therapeutics Inc. (ALLR) in their 13F filings, up 3 from Q4 2024. 6 opened new positions and 3 sold out. The largest holders were Geode Capital Management, LLC ($32K), Morgan Stanley ($22K) and Corsair Capital Management, L.P. ($19K).
- Company
- Allarity Therapeutics Inc.
- CUSIP
- 016744500
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $82K |
| Exits | 3 | $117K |
All 13F filers, Q4 2024 → Q1 2025: 88,072 shares bought and 100,199 shares sold, net −12,127 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Geode Capital Management, LLC | 0.00% | New | 33,921 | $32K |
| Morgan Stanley | 0.00% | New | 23,311 | $22K |
| Corsair Capital Management, L.P. | 0.00% | New | 20,000 | $19K |
| Barclays PLC | 0.00% | New | 10,078 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +10.3% | 4,705 | $4K |
| UBS Group AG | 0.00% | New | 300 | $281 |
| Bank of America Corp. | 0.00% | Add +72.7% | 38 | $36 |
| Osaic Holdings, Inc. | 0.00% | New | 7 | $6 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is ALLR's weight in each manager's 13F, not the share of Allarity Therapeutics Inc. the manager owns.